Sosilya, H.; Diansyah, M.N.; Savitri, M.; Amrita, P.N.A.; Romadhon, P.Z.; Novida, H.; Luthfah, N.; Ashariati, A.; Bintoro, S.U.Y.
Serum Oxidized LDL and Interleukin-10 as Biomarkers for Peripheral Artery Disease in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy. Hemato 2026, 7, 3.
https://doi.org/10.3390/hemato7010003
AMA Style
Sosilya H, Diansyah MN, Savitri M, Amrita PNA, Romadhon PZ, Novida H, Luthfah N, Ashariati A, Bintoro SUY.
Serum Oxidized LDL and Interleukin-10 as Biomarkers for Peripheral Artery Disease in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy. Hemato. 2026; 7(1):3.
https://doi.org/10.3390/hemato7010003
Chicago/Turabian Style
Sosilya, Hernycane, Muhammad Noor Diansyah, Merlyna Savitri, Putu Niken Ayu Amrita, Pradana Zaky Romadhon, Hermina Novida, Nadya Luthfah, Ami Ashariati, and Siprianus Ugroseno Yudho Bintoro.
2026. "Serum Oxidized LDL and Interleukin-10 as Biomarkers for Peripheral Artery Disease in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy" Hemato 7, no. 1: 3.
https://doi.org/10.3390/hemato7010003
APA Style
Sosilya, H., Diansyah, M. N., Savitri, M., Amrita, P. N. A., Romadhon, P. Z., Novida, H., Luthfah, N., Ashariati, A., & Bintoro, S. U. Y.
(2026). Serum Oxidized LDL and Interleukin-10 as Biomarkers for Peripheral Artery Disease in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy. Hemato, 7(1), 3.
https://doi.org/10.3390/hemato7010003
